Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Cash Earnings per Share (CEPS)

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATH BIOGENES (INDIA) Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
   CEPS(Rs) 22.3222.5620.01-33.8410.16

What is the latest Cash Earnings per Share (CEPS) ratio of NATH BIOGENES (INDIA) ?

The latest Cash Earnings per Share (CEPS) ratio of NATH BIOGENES (INDIA) is 22.32 based on Mar2025 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar202522.32
Mar202422.56
Mar202320.01
Mar2022-33.84
Mar201310.16

How is Cash Earnings per Share (CEPS) of NATH BIOGENES (INDIA) Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2025 22.32
-1.06
Mar2024 22.56
12.74
Mar2023 20.01
Positive
Mar2022 -33.84
Negative
Mar2013 10.16 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Cash Earnings per Share (CEPS) ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹279.1 Cr 5.7% 2.7% -1% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,279.5 Cr 4.8% -9.4% -18.9% Stock Analytics
KAVERI SEED COMPANY ₹4,651.6 Cr 8.9% 23.8% -28.9% Stock Analytics
VENKYS (INDIA) ₹2,053.0 Cr 19.7% 10.7% -18% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,131.1 Cr 48% 29.3% -9.3% Stock Analytics
INDO US BIOTECH ₹212.1 Cr 2.6% -22.7% -32.8% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

5.7%

2.7%

-1%

SENSEX

7.8%

-2%

0.2%


You may also like the below Video Courses